| Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat PA Bradford Clinical microbiology reviews 14 (4), 933-951, 2001 | 4968 | 2001 |
| β-Lactams and β-lactamase inhibitors: an overview K Bush, PA Bradford Cold Spring Harbor perspectives in medicine 6 (8), a025247, 2016 | 1421 | 2016 |
| Epidemiology of β-lactamase-producing pathogens K Bush, PA Bradford Clinical microbiology reviews 33 (2), 10.1128/cmr. 00047-19, 2020 | 811 | 2020 |
| Ceftriaxone-resistant Salmonella infection acquired by a child from cattle PD Fey, TJ Safranek, ME Rupp, EF Dunne, E Ribot, PC Iwen, PA Bradford, ... New England Journal of Medicine 342 (17), 1242-1249, 2000 | 785 | 2000 |
| Multiple antibiotic–resistant Klebsiella and Escherichia coli in nursing homes J Wiener, JP Quinn, PA Bradford, RV Goering, C Nathan, K Bush, ... Jama 281 (6), 517-523, 1999 | 762 | 1999 |
| Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein PA Bradford, C Urban, N Mariano, SJ Projan, JJ Rahal, K Bush Antimicrobial agents and chemotherapy 41 (3), 563-569, 1997 | 735 | 1997 |
| Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases … PA Bradford, S Bratu, C Urban, M Visalli, N Mariano, D Landman, ... Clinical infectious diseases 39 (1), 55-60, 2004 | 642 | 2004 |
| Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection M Castanheira, PJ Simner, PA Bradford JAC-antimicrobial resistance 3 (3), dlab092, 2021 | 609 | 2021 |
| Interplay between β-lactamases and new β-lactamase inhibitors K Bush, PA Bradford Nature Reviews Microbiology 17 (5), 295-306, 2019 | 521 | 2019 |
| AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex A Ruzin, D Keeney, PA Bradford Journal of Antimicrobial Chemotherapy 59 (5), 1001-1004, 2007 | 359 | 2007 |
| Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1 CR Dean, MA Visalli, SJ Projan, PE Sum, PA Bradford Antimicrobial agents and chemotherapy 47 (3), 972-978, 2003 | 354 | 2003 |
| In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis PJ Petersen, P Labthavikul, CH Jones, PA Bradford Journal of Antimicrobial Chemotherapy 57 (3), 573-576, 2006 | 317 | 2006 |
| A Novel MATE Family Efflux Pump Contributes to the Reduced Susceptibility of Laboratory-Derived Staphylococcus aureus Mutants to Tigecycline F McAleese, P Petersen, A Ruzin, PM Dunman, E Murphy, SJ Projan, ... Antimicrobial agents and chemotherapy 49 (5), 1865-1871, 2005 | 305 | 2005 |
| Functional, biophysical, and structural bases for antibacterial activity of tigecycline MW Olson, A Ruzin, E Feyfant, TS Rush III, J O'Connell, PA Bradford Antimicrobial agents and chemotherapy 50 (6), 2156-2166, 2006 | 270 | 2006 |
| Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae A Ruzin, MA Visalli, D Keeney, PA Bradford Antimicrobial agents and chemotherapy 49 (3), 1017-1022, 2005 | 258 | 2005 |
| Multiyear, multinational survey of the incidence and global distribution of metallo-β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa KM Kazmierczak, S Rabine, M Hackel, RE McLaughlin, DJ Biedenbach, ... Antimicrobial agents and chemotherapy 60 (2), 1067-1078, 2016 | 255 | 2016 |
| CTX-M-5, a Novel Cefotaxime-Hydrolyzing β-Lactamase from an Outbreak of Salmonella typhimuriumin Latvia PA Bradford, Y Yang, D Sahm, I Grope, D Gardovska, G Storch Antimicrobial agents and chemotherapy 42 (8), 1980-1984, 1998 | 240 | 1998 |
| Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus … SK Bouchillon, BM Johnson, DJ Hoban, JL Johnson, MJ Dowzicky, ... International journal of antimicrobial agents 24 (2), 119-124, 2004 | 235 | 2004 |
| In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other … PJ Petersen, PA Bradford, WJ Weiss, TM Murphy, PE Sum, SJ Projan Antimicrobial agents and chemotherapy 46 (8), 2595-2601, 2002 | 228 | 2002 |
| AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis MA Visalli, E Murphy, SJ Projan, PA Bradford Antimicrobial agents and chemotherapy 47 (2), 665-669, 2003 | 204 | 2003 |
